Company intelligence / Profile preview

MyMeds&Me

London, England, United Kingdom

Ownership: Private
Employees: ~50
Development stage: Other

Overview

MyMeds&Me provides a proven, scalable, global SaaS drug safety platform (Reportum®), used by pharma and CROs worldwide to standardize adverse event and product quality data capture; focused on compliant, real-time safety data management for the pharma industry[1][2][3][4].

Therapeutic areas: Other
Modalities: Non-pharmacological therapyDeviceSoftware (SaaS) platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Auxita (Canadian EMR/EHR company integration)partnerships with major global pharmaceutical companies (undisclosed)

Beyond the preview

Go deeper on MyMeds&Me.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyMeds&Me.

Explore the full profile